BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2310297)

  • 1. [Sialic acid in the serum--an indicator for malignant growth?].
    Schulze G
    Arch Geschwulstforsch; 1990; 60(1):19-24. PubMed ID: 2310297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
    Fischer F; Egg G
    HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K; Bian M; Zhu D; Liu W; Siu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A simple method of measuring serum sialic acid level as a neoplasm marker].
    Tadeusiak W; Sadłowska B; Krawczyński MJ
    Pol Tyg Lek; 1987 Jul 6-7; 42(27-28):845-8. PubMed ID: 3684762
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of serum sialic acid determination in children].
    Seider A; Graf N; Sitzmann FC
    Padiatr Padol; 1992; 27(2):43-6. PubMed ID: 1603602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sialic acid--an acute phase reactant and a concomitant of tumors].
    Simmich T; Dehne A; Laube K; Laube N; Frank KH
    Z Med Lab Diagn; 1991; 32(3-4):188-92. PubMed ID: 1897297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
    Patel PS; Rawal GN; Balar DB
    Gynecol Oncol; 1993 Sep; 50(3):294-9. PubMed ID: 8406190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M; Nayak BR
    Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC; Sprance HE; Carcangiu ML; Chambers JT; Schwartz PE
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
    Vardi JR; Tadros GH; Foemmel R; Shebes M
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.
    Lagana A; Martinez BP; Marino A; Fago G; Bizzarri M
    Anticancer Res; 1995; 15(5B):2341-6. PubMed ID: 8572649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum sialic acid forms as markers for head and neck malignancies.
    Bhatavdekar JM; Vora HH; Patel DD
    Neoplasma; 1988; 35(4):425-34. PubMed ID: 3185839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sialic acid conjugates as biomarkers of tumor growth and therapeutic response in base tongue malignancy.
    Pandit MK; Joshi BH; Patel PS; Chitnis KE; Balar DB
    Indian J Pathol Microbiol; 1987 Jan; 30(1):69-73. PubMed ID: 3679339
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Kumar SS; Reddy H; Semenya KA; Hardy RE
    J Med; 1987; 18(5-6):323-32. PubMed ID: 3505259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic efficiency of serum lipid-bound sialic acid level in malignant pleural effusions].
    Bektemür G; Ozer F; Kanat F; Imecik O
    Tuberk Toraks; 2003; 51(3):265-70. PubMed ID: 15143404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor markers in the monitoring of ovarian cancer].
    Xu SX
    Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):345-7, 383. PubMed ID: 2282861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of sialic acid as a tumor marker].
    Feliú J; Daimiel E; Vicente J; Martín G; García Girón C; Chacón I; González Barón M
    Rev Clin Esp; 1989 May; 184(8):401-3. PubMed ID: 2781072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.